This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Deciphering phosphorylation-dependent signal rewiring in ovarian and endometrial cancer
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
Adapting the Genetics Adviser digital app to support cascade testing
Uncovering targetable interactions of ovarian cancer cells
Prevalence and Experience of Traumatic Stress in Patients with Newly Diagnosed and Recurrent Advanced Ovarian Cancer
Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor
Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor
